MMP2 and neoplasm: The high expression of matrix metalloprotease 2 (MMP2) in the tumour microenvironment was utilised to cleave the PEG chains specifically at the target location, exposing the CPP, in turn promoting the internalisation of the nanocarriers into the tumour cells.